Global Live Biotherapeutic Products (LBP) CDMO Service Market Growth (Status and Outlook) 2026-2032
The global Live Biotherapeutic Products (LBP) CDMO Service market size is predicted to grow from US$ 155 million in 2025 to US$ 616 million in 2032; it is expected to grow at a CAGR of 22.3% from 2026 to 2032.
Live Biotherapeutic Products (LBPs) are biotherapeutic products based on live microorganisms that are intended to treat or prevent disease by modulating the microbiome. These products are usually prepared from specific strains of microorganisms that have potential therapeutic effects, such as improving gut health, boosting the immune system, or reducing inflammation.CDMOs specializing in these fields have the expertise and infrastructure to support developing and manufacturing these complex therapies, which require specialized equipment and facilities. As a result, pharmaceutical and biotech companies can outsource their production to CDMOs, allowing them to focus on research and development.
United States market for Live Biotherapeutic Products (LBP) CDMO Service is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Live Biotherapeutic Products (LBP) CDMO Service is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Live Biotherapeutic Products (LBP) CDMO Service is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Live Biotherapeutic Products (LBP) CDMO Service players cover Lallemand Health Solutions, Wacker Chemie AG, Biose Industrie, List Biological Labs, Inc., NIZO, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Live Biotherapeutic Products (LBP) CDMO Service Industry Forecast? looks at past sales and reviews total world Live Biotherapeutic Products (LBP) CDMO Service sales in 2025, providing a comprehensive analysis by region and market sector of projected Live Biotherapeutic Products (LBP) CDMO Service sales for 2026 through 2032. With Live Biotherapeutic Products (LBP) CDMO Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Live Biotherapeutic Products (LBP) CDMO Service industry.
This Insight Report provides a comprehensive analysis of the global Live Biotherapeutic Products (LBP) CDMO Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Live Biotherapeutic Products (LBP) CDMO Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Live Biotherapeutic Products (LBP) CDMO Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Live Biotherapeutic Products (LBP) CDMO Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Live Biotherapeutic Products (LBP) CDMO Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Live Biotherapeutic Products (LBP) CDMO Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Live Biotherapeutic Products (LBPs) are biotherapeutic products based on live microorganisms that are intended to treat or prevent disease by modulating the microbiome. These products are usually prepared from specific strains of microorganisms that have potential therapeutic effects, such as improving gut health, boosting the immune system, or reducing inflammation.CDMOs specializing in these fields have the expertise and infrastructure to support developing and manufacturing these complex therapies, which require specialized equipment and facilities. As a result, pharmaceutical and biotech companies can outsource their production to CDMOs, allowing them to focus on research and development.
United States market for Live Biotherapeutic Products (LBP) CDMO Service is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Live Biotherapeutic Products (LBP) CDMO Service is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Live Biotherapeutic Products (LBP) CDMO Service is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Live Biotherapeutic Products (LBP) CDMO Service players cover Lallemand Health Solutions, Wacker Chemie AG, Biose Industrie, List Biological Labs, Inc., NIZO, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Live Biotherapeutic Products (LBP) CDMO Service Industry Forecast? looks at past sales and reviews total world Live Biotherapeutic Products (LBP) CDMO Service sales in 2025, providing a comprehensive analysis by region and market sector of projected Live Biotherapeutic Products (LBP) CDMO Service sales for 2026 through 2032. With Live Biotherapeutic Products (LBP) CDMO Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Live Biotherapeutic Products (LBP) CDMO Service industry.
This Insight Report provides a comprehensive analysis of the global Live Biotherapeutic Products (LBP) CDMO Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Live Biotherapeutic Products (LBP) CDMO Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Live Biotherapeutic Products (LBP) CDMO Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Live Biotherapeutic Products (LBP) CDMO Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Live Biotherapeutic Products (LBP) CDMO Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Live Biotherapeutic Products (LBP) CDMO Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Solid Dosage Form
- Liquid Dosage Form
- Digestive System Diseases
- Immune System Diseases
- Metabolic Diseases
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Lallemand Health Solutions
- Wacker Chemie AG
- Biose Industrie
- List Biological Labs, Inc.
- NIZO
- SGS (Quay Pharmaceuticals)
- Assembly Biosciences, Inc.
- Recipharm (Arranta Bio)
- Bacthera (Novonesis+Lonza)
- Smaltis
- Lonza
- vermicon AG
- Cerbios-Pharma SA
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Live Biotherapeutic Products (LBP) CDMO Service Market Size (2021-2032)
2.1.2 Live Biotherapeutic Products (LBP) CDMO Service Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Live Biotherapeutic Products (LBP) CDMO Service by Country/Region (2021, 2025 & 2032)
2.2 Live Biotherapeutic Products (LBP) CDMO Service Segment by Type
2.2.1 Solid Dosage Form
2.2.2 Liquid Dosage Form
2.2.3 Live Biotherapeutic Products (LBP) CDMO Service Market Size by Type
2.2.3.1 Live Biotherapeutic Products (LBP) CDMO Service Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Type (2021-2026)
2.3 Live Biotherapeutic Products (LBP) CDMO Service Segment by Application
2.3.1 Digestive System Diseases
2.3.2 Immune System Diseases
2.3.3 Metabolic Diseases
2.3.4 Other
2.3.5 Live Biotherapeutic Products (LBP) CDMO Service Market Size by Application
2.3.5.1 Live Biotherapeutic Products (LBP) CDMO Service Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.5.2 Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Application (2021-2026)
3 LIVE BIOTHERAPEUTIC PRODUCTS (LBP) CDMO SERVICE MARKET SIZE BY PLAYER
3.1 Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Player
3.1.1 Global Live Biotherapeutic Products (LBP) CDMO Service Revenue by Player (2021-2026)
3.1.2 Global Live Biotherapeutic Products (LBP) CDMO Service Revenue Market Share by Player (2021-2026)
3.2 Global Live Biotherapeutic Products (LBP) CDMO Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 LIVE BIOTHERAPEUTIC PRODUCTS (LBP) CDMO SERVICE BY REGION
4.1 Live Biotherapeutic Products (LBP) CDMO Service Market Size by Region (2021-2026)
4.2 Global Live Biotherapeutic Products (LBP) CDMO Service Annual Revenue by Country/Region (2021-2026)
4.3 Americas Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth (2021-2026)
4.4 APAC Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth (2021-2026)
4.5 Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth (2021-2026)
4.6 Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Live Biotherapeutic Products (LBP) CDMO Service Market Size by Country (2021-2026)
5.2 Americas Live Biotherapeutic Products (LBP) CDMO Service Market Size by Type (2021-2026)
5.3 Americas Live Biotherapeutic Products (LBP) CDMO Service Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Live Biotherapeutic Products (LBP) CDMO Service Market Size by Region (2021-2026)
6.2 APAC Live Biotherapeutic Products (LBP) CDMO Service Market Size by Type (2021-2026)
6.3 APAC Live Biotherapeutic Products (LBP) CDMO Service Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size by Country (2021-2026)
7.2 Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size by Type (2021-2026)
7.3 Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service by Region (2021-2026)
8.2 Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size by Type (2021-2026)
8.3 Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS (LBP) CDMO SERVICE MARKET FORECAST
10.1 Global Live Biotherapeutic Products (LBP) CDMO Service Forecast by Region (2027-2032)
10.1.1 Global Live Biotherapeutic Products (LBP) CDMO Service Forecast by Region (2027-2032)
10.1.2 Americas Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.1.3 APAC Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.1.4 Europe Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.1.5 Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.2 Americas Live Biotherapeutic Products (LBP) CDMO Service Forecast by Country (2027-2032)
10.2.1 United States Market Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.2.2 Canada Market Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.2.3 Mexico Market Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.2.4 Brazil Market Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.3 APAC Live Biotherapeutic Products (LBP) CDMO Service Forecast by Region (2027-2032)
10.3.1 China Live Biotherapeutic Products (LBP) CDMO Service Market Forecast
10.3.2 Japan Market Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.3.3 Korea Market Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.3.4 Southeast Asia Market Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.3.5 India Market Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.3.6 Australia Market Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.4 Europe Live Biotherapeutic Products (LBP) CDMO Service Forecast by Country (2027-2032)
10.4.1 Germany Market Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.4.2 France Market Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.4.3 UK Market Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.4.4 Italy Market Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.4.5 Russia Market Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.5 Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Forecast by Region (2027-2032)
10.5.1 Egypt Market Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.5.2 South Africa Market Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.5.3 Israel Market Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.5.4 Turkey Market Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.6 Global Live Biotherapeutic Products (LBP) CDMO Service Forecast by Type (2027-2032)
10.7 Global Live Biotherapeutic Products (LBP) CDMO Service Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Live Biotherapeutic Products (LBP) CDMO Service Forecast
11 KEY PLAYERS ANALYSIS
11.1 Lallemand Health Solutions
11.1.1 Lallemand Health Solutions Company Information
11.1.2 Lallemand Health Solutions Live Biotherapeutic Products (LBP) CDMO Service Product Offered
11.1.3 Lallemand Health Solutions Live Biotherapeutic Products (LBP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Lallemand Health Solutions Main Business Overview
11.1.5 Lallemand Health Solutions Latest Developments
11.2 Wacker Chemie AG
11.2.1 Wacker Chemie AG Company Information
11.2.2 Wacker Chemie AG Live Biotherapeutic Products (LBP) CDMO Service Product Offered
11.2.3 Wacker Chemie AG Live Biotherapeutic Products (LBP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Wacker Chemie AG Main Business Overview
11.2.5 Wacker Chemie AG Latest Developments
11.3 Biose Industrie
11.3.1 Biose Industrie Company Information
11.3.2 Biose Industrie Live Biotherapeutic Products (LBP) CDMO Service Product Offered
11.3.3 Biose Industrie Live Biotherapeutic Products (LBP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Biose Industrie Main Business Overview
11.3.5 Biose Industrie Latest Developments
11.4 List Biological Labs, Inc.
11.4.1 List Biological Labs, Inc. Company Information
11.4.2 List Biological Labs, Inc. Live Biotherapeutic Products (LBP) CDMO Service Product Offered
11.4.3 List Biological Labs, Inc. Live Biotherapeutic Products (LBP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 List Biological Labs, Inc. Main Business Overview
11.4.5 List Biological Labs, Inc. Latest Developments
11.5 NIZO
11.5.1 NIZO Company Information
11.5.2 NIZO Live Biotherapeutic Products (LBP) CDMO Service Product Offered
11.5.3 NIZO Live Biotherapeutic Products (LBP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 NIZO Main Business Overview
11.5.5 NIZO Latest Developments
11.6 SGS (Quay Pharmaceuticals)
11.6.1 SGS (Quay Pharmaceuticals) Company Information
11.6.2 SGS (Quay Pharmaceuticals) Live Biotherapeutic Products (LBP) CDMO Service Product Offered
11.6.3 SGS (Quay Pharmaceuticals) Live Biotherapeutic Products (LBP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 SGS (Quay Pharmaceuticals) Main Business Overview
11.6.5 SGS (Quay Pharmaceuticals) Latest Developments
11.7 Assembly Biosciences, Inc.
11.7.1 Assembly Biosciences, Inc. Company Information
11.7.2 Assembly Biosciences, Inc. Live Biotherapeutic Products (LBP) CDMO Service Product Offered
11.7.3 Assembly Biosciences, Inc. Live Biotherapeutic Products (LBP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Assembly Biosciences, Inc. Main Business Overview
11.7.5 Assembly Biosciences, Inc. Latest Developments
11.8 Recipharm (Arranta Bio)
11.8.1 Recipharm (Arranta Bio) Company Information
11.8.2 Recipharm (Arranta Bio) Live Biotherapeutic Products (LBP) CDMO Service Product Offered
11.8.3 Recipharm (Arranta Bio) Live Biotherapeutic Products (LBP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Recipharm (Arranta Bio) Main Business Overview
11.8.5 Recipharm (Arranta Bio) Latest Developments
11.9 Bacthera (Novonesis+Lonza)
11.9.1 Bacthera (Novonesis+Lonza) Company Information
11.9.2 Bacthera (Novonesis+Lonza) Live Biotherapeutic Products (LBP) CDMO Service Product Offered
11.9.3 Bacthera (Novonesis+Lonza) Live Biotherapeutic Products (LBP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Bacthera (Novonesis+Lonza) Main Business Overview
11.9.5 Bacthera (Novonesis+Lonza) Latest Developments
11.10 Smaltis
11.10.1 Smaltis Company Information
11.10.2 Smaltis Live Biotherapeutic Products (LBP) CDMO Service Product Offered
11.10.3 Smaltis Live Biotherapeutic Products (LBP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Smaltis Main Business Overview
11.10.5 Smaltis Latest Developments
11.11 Lonza
11.11.1 Lonza Company Information
11.11.2 Lonza Live Biotherapeutic Products (LBP) CDMO Service Product Offered
11.11.3 Lonza Live Biotherapeutic Products (LBP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Lonza Main Business Overview
11.11.5 Lonza Latest Developments
11.12 vermicon AG
11.12.1 vermicon AG Company Information
11.12.2 vermicon AG Live Biotherapeutic Products (LBP) CDMO Service Product Offered
11.12.3 vermicon AG Live Biotherapeutic Products (LBP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 vermicon AG Main Business Overview
11.12.5 vermicon AG Latest Developments
11.13 Cerbios-Pharma SA
11.13.1 Cerbios-Pharma SA Company Information
11.13.2 Cerbios-Pharma SA Live Biotherapeutic Products (LBP) CDMO Service Product Offered
11.13.3 Cerbios-Pharma SA Live Biotherapeutic Products (LBP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Cerbios-Pharma SA Main Business Overview
11.13.5 Cerbios-Pharma SA Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Live Biotherapeutic Products (LBP) CDMO Service Market Size (2021-2032)
2.1.2 Live Biotherapeutic Products (LBP) CDMO Service Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Live Biotherapeutic Products (LBP) CDMO Service by Country/Region (2021, 2025 & 2032)
2.2 Live Biotherapeutic Products (LBP) CDMO Service Segment by Type
2.2.1 Solid Dosage Form
2.2.2 Liquid Dosage Form
2.2.3 Live Biotherapeutic Products (LBP) CDMO Service Market Size by Type
2.2.3.1 Live Biotherapeutic Products (LBP) CDMO Service Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Type (2021-2026)
2.3 Live Biotherapeutic Products (LBP) CDMO Service Segment by Application
2.3.1 Digestive System Diseases
2.3.2 Immune System Diseases
2.3.3 Metabolic Diseases
2.3.4 Other
2.3.5 Live Biotherapeutic Products (LBP) CDMO Service Market Size by Application
2.3.5.1 Live Biotherapeutic Products (LBP) CDMO Service Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.5.2 Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Application (2021-2026)
3 LIVE BIOTHERAPEUTIC PRODUCTS (LBP) CDMO SERVICE MARKET SIZE BY PLAYER
3.1 Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Player
3.1.1 Global Live Biotherapeutic Products (LBP) CDMO Service Revenue by Player (2021-2026)
3.1.2 Global Live Biotherapeutic Products (LBP) CDMO Service Revenue Market Share by Player (2021-2026)
3.2 Global Live Biotherapeutic Products (LBP) CDMO Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 LIVE BIOTHERAPEUTIC PRODUCTS (LBP) CDMO SERVICE BY REGION
4.1 Live Biotherapeutic Products (LBP) CDMO Service Market Size by Region (2021-2026)
4.2 Global Live Biotherapeutic Products (LBP) CDMO Service Annual Revenue by Country/Region (2021-2026)
4.3 Americas Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth (2021-2026)
4.4 APAC Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth (2021-2026)
4.5 Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth (2021-2026)
4.6 Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Live Biotherapeutic Products (LBP) CDMO Service Market Size by Country (2021-2026)
5.2 Americas Live Biotherapeutic Products (LBP) CDMO Service Market Size by Type (2021-2026)
5.3 Americas Live Biotherapeutic Products (LBP) CDMO Service Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Live Biotherapeutic Products (LBP) CDMO Service Market Size by Region (2021-2026)
6.2 APAC Live Biotherapeutic Products (LBP) CDMO Service Market Size by Type (2021-2026)
6.3 APAC Live Biotherapeutic Products (LBP) CDMO Service Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size by Country (2021-2026)
7.2 Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size by Type (2021-2026)
7.3 Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service by Region (2021-2026)
8.2 Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size by Type (2021-2026)
8.3 Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS (LBP) CDMO SERVICE MARKET FORECAST
10.1 Global Live Biotherapeutic Products (LBP) CDMO Service Forecast by Region (2027-2032)
10.1.1 Global Live Biotherapeutic Products (LBP) CDMO Service Forecast by Region (2027-2032)
10.1.2 Americas Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.1.3 APAC Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.1.4 Europe Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.1.5 Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.2 Americas Live Biotherapeutic Products (LBP) CDMO Service Forecast by Country (2027-2032)
10.2.1 United States Market Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.2.2 Canada Market Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.2.3 Mexico Market Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.2.4 Brazil Market Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.3 APAC Live Biotherapeutic Products (LBP) CDMO Service Forecast by Region (2027-2032)
10.3.1 China Live Biotherapeutic Products (LBP) CDMO Service Market Forecast
10.3.2 Japan Market Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.3.3 Korea Market Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.3.4 Southeast Asia Market Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.3.5 India Market Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.3.6 Australia Market Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.4 Europe Live Biotherapeutic Products (LBP) CDMO Service Forecast by Country (2027-2032)
10.4.1 Germany Market Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.4.2 France Market Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.4.3 UK Market Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.4.4 Italy Market Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.4.5 Russia Market Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.5 Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Forecast by Region (2027-2032)
10.5.1 Egypt Market Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.5.2 South Africa Market Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.5.3 Israel Market Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.5.4 Turkey Market Live Biotherapeutic Products (LBP) CDMO Service Forecast
10.6 Global Live Biotherapeutic Products (LBP) CDMO Service Forecast by Type (2027-2032)
10.7 Global Live Biotherapeutic Products (LBP) CDMO Service Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Live Biotherapeutic Products (LBP) CDMO Service Forecast
11 KEY PLAYERS ANALYSIS
11.1 Lallemand Health Solutions
11.1.1 Lallemand Health Solutions Company Information
11.1.2 Lallemand Health Solutions Live Biotherapeutic Products (LBP) CDMO Service Product Offered
11.1.3 Lallemand Health Solutions Live Biotherapeutic Products (LBP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Lallemand Health Solutions Main Business Overview
11.1.5 Lallemand Health Solutions Latest Developments
11.2 Wacker Chemie AG
11.2.1 Wacker Chemie AG Company Information
11.2.2 Wacker Chemie AG Live Biotherapeutic Products (LBP) CDMO Service Product Offered
11.2.3 Wacker Chemie AG Live Biotherapeutic Products (LBP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Wacker Chemie AG Main Business Overview
11.2.5 Wacker Chemie AG Latest Developments
11.3 Biose Industrie
11.3.1 Biose Industrie Company Information
11.3.2 Biose Industrie Live Biotherapeutic Products (LBP) CDMO Service Product Offered
11.3.3 Biose Industrie Live Biotherapeutic Products (LBP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Biose Industrie Main Business Overview
11.3.5 Biose Industrie Latest Developments
11.4 List Biological Labs, Inc.
11.4.1 List Biological Labs, Inc. Company Information
11.4.2 List Biological Labs, Inc. Live Biotherapeutic Products (LBP) CDMO Service Product Offered
11.4.3 List Biological Labs, Inc. Live Biotherapeutic Products (LBP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 List Biological Labs, Inc. Main Business Overview
11.4.5 List Biological Labs, Inc. Latest Developments
11.5 NIZO
11.5.1 NIZO Company Information
11.5.2 NIZO Live Biotherapeutic Products (LBP) CDMO Service Product Offered
11.5.3 NIZO Live Biotherapeutic Products (LBP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 NIZO Main Business Overview
11.5.5 NIZO Latest Developments
11.6 SGS (Quay Pharmaceuticals)
11.6.1 SGS (Quay Pharmaceuticals) Company Information
11.6.2 SGS (Quay Pharmaceuticals) Live Biotherapeutic Products (LBP) CDMO Service Product Offered
11.6.3 SGS (Quay Pharmaceuticals) Live Biotherapeutic Products (LBP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 SGS (Quay Pharmaceuticals) Main Business Overview
11.6.5 SGS (Quay Pharmaceuticals) Latest Developments
11.7 Assembly Biosciences, Inc.
11.7.1 Assembly Biosciences, Inc. Company Information
11.7.2 Assembly Biosciences, Inc. Live Biotherapeutic Products (LBP) CDMO Service Product Offered
11.7.3 Assembly Biosciences, Inc. Live Biotherapeutic Products (LBP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Assembly Biosciences, Inc. Main Business Overview
11.7.5 Assembly Biosciences, Inc. Latest Developments
11.8 Recipharm (Arranta Bio)
11.8.1 Recipharm (Arranta Bio) Company Information
11.8.2 Recipharm (Arranta Bio) Live Biotherapeutic Products (LBP) CDMO Service Product Offered
11.8.3 Recipharm (Arranta Bio) Live Biotherapeutic Products (LBP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Recipharm (Arranta Bio) Main Business Overview
11.8.5 Recipharm (Arranta Bio) Latest Developments
11.9 Bacthera (Novonesis+Lonza)
11.9.1 Bacthera (Novonesis+Lonza) Company Information
11.9.2 Bacthera (Novonesis+Lonza) Live Biotherapeutic Products (LBP) CDMO Service Product Offered
11.9.3 Bacthera (Novonesis+Lonza) Live Biotherapeutic Products (LBP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Bacthera (Novonesis+Lonza) Main Business Overview
11.9.5 Bacthera (Novonesis+Lonza) Latest Developments
11.10 Smaltis
11.10.1 Smaltis Company Information
11.10.2 Smaltis Live Biotherapeutic Products (LBP) CDMO Service Product Offered
11.10.3 Smaltis Live Biotherapeutic Products (LBP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Smaltis Main Business Overview
11.10.5 Smaltis Latest Developments
11.11 Lonza
11.11.1 Lonza Company Information
11.11.2 Lonza Live Biotherapeutic Products (LBP) CDMO Service Product Offered
11.11.3 Lonza Live Biotherapeutic Products (LBP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Lonza Main Business Overview
11.11.5 Lonza Latest Developments
11.12 vermicon AG
11.12.1 vermicon AG Company Information
11.12.2 vermicon AG Live Biotherapeutic Products (LBP) CDMO Service Product Offered
11.12.3 vermicon AG Live Biotherapeutic Products (LBP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 vermicon AG Main Business Overview
11.12.5 vermicon AG Latest Developments
11.13 Cerbios-Pharma SA
11.13.1 Cerbios-Pharma SA Company Information
11.13.2 Cerbios-Pharma SA Live Biotherapeutic Products (LBP) CDMO Service Product Offered
11.13.3 Cerbios-Pharma SA Live Biotherapeutic Products (LBP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Cerbios-Pharma SA Main Business Overview
11.13.5 Cerbios-Pharma SA Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Live Biotherapeutic Products (LBP) CDMO Service Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Live Biotherapeutic Products (LBP) CDMO Service Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Solid Dosage Form
Table 4. Major Players of Liquid Dosage Form
Table 5. Live Biotherapeutic Products (LBP) CDMO Service Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Type (2021-2026)
Table 8. Live Biotherapeutic Products (LBP) CDMO Service Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Application (2021-2026)
Table 11. Global Live Biotherapeutic Products (LBP) CDMO Service Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Live Biotherapeutic Products (LBP) CDMO Service Revenue Market Share by Player (2021-2026)
Table 13. Live Biotherapeutic Products (LBP) CDMO Service Key Players Head office and Products Offered
Table 14. Live Biotherapeutic Products (LBP) CDMO Service Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Region (2021-2026)
Table 19. Global Live Biotherapeutic Products (LBP) CDMO Service Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Live Biotherapeutic Products (LBP) CDMO Service Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Live Biotherapeutic Products (LBP) CDMO Service Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Country (2021-2026)
Table 23. Americas Live Biotherapeutic Products (LBP) CDMO Service Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Type (2021-2026)
Table 25. Americas Live Biotherapeutic Products (LBP) CDMO Service Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Application (2021-2026)
Table 27. APAC Live Biotherapeutic Products (LBP) CDMO Service Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Region (2021-2026)
Table 29. APAC Live Biotherapeutic Products (LBP) CDMO Service Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Live Biotherapeutic Products (LBP) CDMO Service Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Country (2021-2026)
Table 33. Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Live Biotherapeutic Products (LBP) CDMO Service
Table 39. Key Market Challenges & Risks of Live Biotherapeutic Products (LBP) CDMO Service
Table 40. Key Industry Trends of Live Biotherapeutic Products (LBP) CDMO Service
Table 41. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Lallemand Health Solutions Details, Company Type, Live Biotherapeutic Products (LBP) CDMO Service Area Served and Its Competitors
Table 46. Lallemand Health Solutions Live Biotherapeutic Products (LBP) CDMO Service Product Offered
Table 47. Lallemand Health Solutions Live Biotherapeutic Products (LBP) CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Lallemand Health Solutions Main Business
Table 49. Lallemand Health Solutions Latest Developments
Table 50. Wacker Chemie AG Details, Company Type, Live Biotherapeutic Products (LBP) CDMO Service Area Served and Its Competitors
Table 51. Wacker Chemie AG Live Biotherapeutic Products (LBP) CDMO Service Product Offered
Table 52. Wacker Chemie AG Live Biotherapeutic Products (LBP) CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Wacker Chemie AG Main Business
Table 54. Wacker Chemie AG Latest Developments
Table 55. Biose Industrie Details, Company Type, Live Biotherapeutic Products (LBP) CDMO Service Area Served and Its Competitors
Table 56. Biose Industrie Live Biotherapeutic Products (LBP) CDMO Service Product Offered
Table 57. Biose Industrie Live Biotherapeutic Products (LBP) CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Biose Industrie Main Business
Table 59. Biose Industrie Latest Developments
Table 60. List Biological Labs, Inc. Details, Company Type, Live Biotherapeutic Products (LBP) CDMO Service Area Served and Its Competitors
Table 61. List Biological Labs, Inc. Live Biotherapeutic Products (LBP) CDMO Service Product Offered
Table 62. List Biological Labs, Inc. Live Biotherapeutic Products (LBP) CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. List Biological Labs, Inc. Main Business
Table 64. List Biological Labs, Inc. Latest Developments
Table 65. NIZO Details, Company Type, Live Biotherapeutic Products (LBP) CDMO Service Area Served and Its Competitors
Table 66. NIZO Live Biotherapeutic Products (LBP) CDMO Service Product Offered
Table 67. NIZO Live Biotherapeutic Products (LBP) CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. NIZO Main Business
Table 69. NIZO Latest Developments
Table 70. SGS (Quay Pharmaceuticals) Details, Company Type, Live Biotherapeutic Products (LBP) CDMO Service Area Served and Its Competitors
Table 71. SGS (Quay Pharmaceuticals) Live Biotherapeutic Products (LBP) CDMO Service Product Offered
Table 72. SGS (Quay Pharmaceuticals) Live Biotherapeutic Products (LBP) CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. SGS (Quay Pharmaceuticals) Main Business
Table 74. SGS (Quay Pharmaceuticals) Latest Developments
Table 75. Assembly Biosciences, Inc. Details, Company Type, Live Biotherapeutic Products (LBP) CDMO Service Area Served and Its Competitors
Table 76. Assembly Biosciences, Inc. Live Biotherapeutic Products (LBP) CDMO Service Product Offered
Table 77. Assembly Biosciences, Inc. Live Biotherapeutic Products (LBP) CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Assembly Biosciences, Inc. Main Business
Table 79. Assembly Biosciences, Inc. Latest Developments
Table 80. Recipharm (Arranta Bio) Details, Company Type, Live Biotherapeutic Products (LBP) CDMO Service Area Served and Its Competitors
Table 81. Recipharm (Arranta Bio) Live Biotherapeutic Products (LBP) CDMO Service Product Offered
Table 82. Recipharm (Arranta Bio) Live Biotherapeutic Products (LBP) CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Recipharm (Arranta Bio) Main Business
Table 84. Recipharm (Arranta Bio) Latest Developments
Table 85. Bacthera (Novonesis+Lonza) Details, Company Type, Live Biotherapeutic Products (LBP) CDMO Service Area Served and Its Competitors
Table 86. Bacthera (Novonesis+Lonza) Live Biotherapeutic Products (LBP) CDMO Service Product Offered
Table 87. Bacthera (Novonesis+Lonza) Live Biotherapeutic Products (LBP) CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Bacthera (Novonesis+Lonza) Main Business
Table 89. Bacthera (Novonesis+Lonza) Latest Developments
Table 90. Smaltis Details, Company Type, Live Biotherapeutic Products (LBP) CDMO Service Area Served and Its Competitors
Table 91. Smaltis Live Biotherapeutic Products (LBP) CDMO Service Product Offered
Table 92. Smaltis Live Biotherapeutic Products (LBP) CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Smaltis Main Business
Table 94. Smaltis Latest Developments
Table 95. Lonza Details, Company Type, Live Biotherapeutic Products (LBP) CDMO Service Area Served and Its Competitors
Table 96. Lonza Live Biotherapeutic Products (LBP) CDMO Service Product Offered
Table 97. Lonza Live Biotherapeutic Products (LBP) CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Lonza Main Business
Table 99. Lonza Latest Developments
Table 100. vermicon AG Details, Company Type, Live Biotherapeutic Products (LBP) CDMO Service Area Served and Its Competitors
Table 101. vermicon AG Live Biotherapeutic Products (LBP) CDMO Service Product Offered
Table 102. vermicon AG Live Biotherapeutic Products (LBP) CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. vermicon AG Main Business
Table 104. vermicon AG Latest Developments
Table 105. Cerbios-Pharma SA Details, Company Type, Live Biotherapeutic Products (LBP) CDMO Service Area Served and Its Competitors
Table 106. Cerbios-Pharma SA Live Biotherapeutic Products (LBP) CDMO Service Product Offered
Table 107. Cerbios-Pharma SA Live Biotherapeutic Products (LBP) CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Cerbios-Pharma SA Main Business
Table 109. Cerbios-Pharma SA Latest Developments
Table 1. Live Biotherapeutic Products (LBP) CDMO Service Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Live Biotherapeutic Products (LBP) CDMO Service Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Solid Dosage Form
Table 4. Major Players of Liquid Dosage Form
Table 5. Live Biotherapeutic Products (LBP) CDMO Service Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Type (2021-2026)
Table 8. Live Biotherapeutic Products (LBP) CDMO Service Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Application (2021-2026)
Table 11. Global Live Biotherapeutic Products (LBP) CDMO Service Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Live Biotherapeutic Products (LBP) CDMO Service Revenue Market Share by Player (2021-2026)
Table 13. Live Biotherapeutic Products (LBP) CDMO Service Key Players Head office and Products Offered
Table 14. Live Biotherapeutic Products (LBP) CDMO Service Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Region (2021-2026)
Table 19. Global Live Biotherapeutic Products (LBP) CDMO Service Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Live Biotherapeutic Products (LBP) CDMO Service Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Live Biotherapeutic Products (LBP) CDMO Service Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Country (2021-2026)
Table 23. Americas Live Biotherapeutic Products (LBP) CDMO Service Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Type (2021-2026)
Table 25. Americas Live Biotherapeutic Products (LBP) CDMO Service Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Application (2021-2026)
Table 27. APAC Live Biotherapeutic Products (LBP) CDMO Service Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Region (2021-2026)
Table 29. APAC Live Biotherapeutic Products (LBP) CDMO Service Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Live Biotherapeutic Products (LBP) CDMO Service Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Country (2021-2026)
Table 33. Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Live Biotherapeutic Products (LBP) CDMO Service
Table 39. Key Market Challenges & Risks of Live Biotherapeutic Products (LBP) CDMO Service
Table 40. Key Industry Trends of Live Biotherapeutic Products (LBP) CDMO Service
Table 41. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Lallemand Health Solutions Details, Company Type, Live Biotherapeutic Products (LBP) CDMO Service Area Served and Its Competitors
Table 46. Lallemand Health Solutions Live Biotherapeutic Products (LBP) CDMO Service Product Offered
Table 47. Lallemand Health Solutions Live Biotherapeutic Products (LBP) CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Lallemand Health Solutions Main Business
Table 49. Lallemand Health Solutions Latest Developments
Table 50. Wacker Chemie AG Details, Company Type, Live Biotherapeutic Products (LBP) CDMO Service Area Served and Its Competitors
Table 51. Wacker Chemie AG Live Biotherapeutic Products (LBP) CDMO Service Product Offered
Table 52. Wacker Chemie AG Live Biotherapeutic Products (LBP) CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Wacker Chemie AG Main Business
Table 54. Wacker Chemie AG Latest Developments
Table 55. Biose Industrie Details, Company Type, Live Biotherapeutic Products (LBP) CDMO Service Area Served and Its Competitors
Table 56. Biose Industrie Live Biotherapeutic Products (LBP) CDMO Service Product Offered
Table 57. Biose Industrie Live Biotherapeutic Products (LBP) CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Biose Industrie Main Business
Table 59. Biose Industrie Latest Developments
Table 60. List Biological Labs, Inc. Details, Company Type, Live Biotherapeutic Products (LBP) CDMO Service Area Served and Its Competitors
Table 61. List Biological Labs, Inc. Live Biotherapeutic Products (LBP) CDMO Service Product Offered
Table 62. List Biological Labs, Inc. Live Biotherapeutic Products (LBP) CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. List Biological Labs, Inc. Main Business
Table 64. List Biological Labs, Inc. Latest Developments
Table 65. NIZO Details, Company Type, Live Biotherapeutic Products (LBP) CDMO Service Area Served and Its Competitors
Table 66. NIZO Live Biotherapeutic Products (LBP) CDMO Service Product Offered
Table 67. NIZO Live Biotherapeutic Products (LBP) CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. NIZO Main Business
Table 69. NIZO Latest Developments
Table 70. SGS (Quay Pharmaceuticals) Details, Company Type, Live Biotherapeutic Products (LBP) CDMO Service Area Served and Its Competitors
Table 71. SGS (Quay Pharmaceuticals) Live Biotherapeutic Products (LBP) CDMO Service Product Offered
Table 72. SGS (Quay Pharmaceuticals) Live Biotherapeutic Products (LBP) CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. SGS (Quay Pharmaceuticals) Main Business
Table 74. SGS (Quay Pharmaceuticals) Latest Developments
Table 75. Assembly Biosciences, Inc. Details, Company Type, Live Biotherapeutic Products (LBP) CDMO Service Area Served and Its Competitors
Table 76. Assembly Biosciences, Inc. Live Biotherapeutic Products (LBP) CDMO Service Product Offered
Table 77. Assembly Biosciences, Inc. Live Biotherapeutic Products (LBP) CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Assembly Biosciences, Inc. Main Business
Table 79. Assembly Biosciences, Inc. Latest Developments
Table 80. Recipharm (Arranta Bio) Details, Company Type, Live Biotherapeutic Products (LBP) CDMO Service Area Served and Its Competitors
Table 81. Recipharm (Arranta Bio) Live Biotherapeutic Products (LBP) CDMO Service Product Offered
Table 82. Recipharm (Arranta Bio) Live Biotherapeutic Products (LBP) CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Recipharm (Arranta Bio) Main Business
Table 84. Recipharm (Arranta Bio) Latest Developments
Table 85. Bacthera (Novonesis+Lonza) Details, Company Type, Live Biotherapeutic Products (LBP) CDMO Service Area Served and Its Competitors
Table 86. Bacthera (Novonesis+Lonza) Live Biotherapeutic Products (LBP) CDMO Service Product Offered
Table 87. Bacthera (Novonesis+Lonza) Live Biotherapeutic Products (LBP) CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Bacthera (Novonesis+Lonza) Main Business
Table 89. Bacthera (Novonesis+Lonza) Latest Developments
Table 90. Smaltis Details, Company Type, Live Biotherapeutic Products (LBP) CDMO Service Area Served and Its Competitors
Table 91. Smaltis Live Biotherapeutic Products (LBP) CDMO Service Product Offered
Table 92. Smaltis Live Biotherapeutic Products (LBP) CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Smaltis Main Business
Table 94. Smaltis Latest Developments
Table 95. Lonza Details, Company Type, Live Biotherapeutic Products (LBP) CDMO Service Area Served and Its Competitors
Table 96. Lonza Live Biotherapeutic Products (LBP) CDMO Service Product Offered
Table 97. Lonza Live Biotherapeutic Products (LBP) CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Lonza Main Business
Table 99. Lonza Latest Developments
Table 100. vermicon AG Details, Company Type, Live Biotherapeutic Products (LBP) CDMO Service Area Served and Its Competitors
Table 101. vermicon AG Live Biotherapeutic Products (LBP) CDMO Service Product Offered
Table 102. vermicon AG Live Biotherapeutic Products (LBP) CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. vermicon AG Main Business
Table 104. vermicon AG Latest Developments
Table 105. Cerbios-Pharma SA Details, Company Type, Live Biotherapeutic Products (LBP) CDMO Service Area Served and Its Competitors
Table 106. Cerbios-Pharma SA Live Biotherapeutic Products (LBP) CDMO Service Product Offered
Table 107. Cerbios-Pharma SA Live Biotherapeutic Products (LBP) CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Cerbios-Pharma SA Main Business
Table 109. Cerbios-Pharma SA Latest Developments
LIST OF FIGURES
Figure 1. Live Biotherapeutic Products (LBP) CDMO Service Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Live Biotherapeutic Products (LBP) CDMO Service Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Live Biotherapeutic Products (LBP) CDMO Service Sales Market Share by Country/Region (2025)
Figure 8. Live Biotherapeutic Products (LBP) CDMO Service Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Type in 2025
Figure 10. Live Biotherapeutic Products (LBP) CDMO Service in Digestive System Diseases
Figure 11. Global Live Biotherapeutic Products (LBP) CDMO Service Market: Digestive System Diseases (2021-2026) & ($ millions)
Figure 12. Live Biotherapeutic Products (LBP) CDMO Service in Immune System Diseases
Figure 13. Global Live Biotherapeutic Products (LBP) CDMO Service Market: Immune System Diseases (2021-2026) & ($ millions)
Figure 14. Live Biotherapeutic Products (LBP) CDMO Service in Metabolic Diseases
Figure 15. Global Live Biotherapeutic Products (LBP) CDMO Service Market: Metabolic Diseases (2021-2026) & ($ millions)
Figure 16. Live Biotherapeutic Products (LBP) CDMO Service in Other
Figure 17. Global Live Biotherapeutic Products (LBP) CDMO Service Market: Other (2021-2026) & ($ millions)
Figure 18. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Application in 2025
Figure 19. Global Live Biotherapeutic Products (LBP) CDMO Service Revenue Market Share by Player in 2025
Figure 20. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Region (2021-2026)
Figure 21. Americas Live Biotherapeutic Products (LBP) CDMO Service Market Size 2021-2026 ($ millions)
Figure 22. APAC Live Biotherapeutic Products (LBP) CDMO Service Market Size 2021-2026 ($ millions)
Figure 23. Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size 2021-2026 ($ millions)
Figure 25. Americas Live Biotherapeutic Products (LBP) CDMO Service Value Market Share by Country in 2025
Figure 26. United States Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Region in 2025
Figure 31. APAC Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Type (2021-2026)
Figure 32. APAC Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Application (2021-2026)
Figure 33. China Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 37. India Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Country in 2025
Figure 40. Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Type (2021-2026)
Figure 41. Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Application (2021-2026)
Figure 42. Germany Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 43. France Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 56. APAC Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 57. Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 59. United States Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 60. Canada Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 61. Mexico Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 62. Brazil Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 63. China Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 64. Japan Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 65. Korea Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 67. India Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 68. Australia Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 69. Germany Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 70. France Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 71. UK Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 72. Italy Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 73. Russia Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 74. Egypt Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 75. South Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 76. Israel Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 77. Turkey Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 78. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 1. Live Biotherapeutic Products (LBP) CDMO Service Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Live Biotherapeutic Products (LBP) CDMO Service Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Live Biotherapeutic Products (LBP) CDMO Service Sales Market Share by Country/Region (2025)
Figure 8. Live Biotherapeutic Products (LBP) CDMO Service Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Type in 2025
Figure 10. Live Biotherapeutic Products (LBP) CDMO Service in Digestive System Diseases
Figure 11. Global Live Biotherapeutic Products (LBP) CDMO Service Market: Digestive System Diseases (2021-2026) & ($ millions)
Figure 12. Live Biotherapeutic Products (LBP) CDMO Service in Immune System Diseases
Figure 13. Global Live Biotherapeutic Products (LBP) CDMO Service Market: Immune System Diseases (2021-2026) & ($ millions)
Figure 14. Live Biotherapeutic Products (LBP) CDMO Service in Metabolic Diseases
Figure 15. Global Live Biotherapeutic Products (LBP) CDMO Service Market: Metabolic Diseases (2021-2026) & ($ millions)
Figure 16. Live Biotherapeutic Products (LBP) CDMO Service in Other
Figure 17. Global Live Biotherapeutic Products (LBP) CDMO Service Market: Other (2021-2026) & ($ millions)
Figure 18. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Application in 2025
Figure 19. Global Live Biotherapeutic Products (LBP) CDMO Service Revenue Market Share by Player in 2025
Figure 20. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Region (2021-2026)
Figure 21. Americas Live Biotherapeutic Products (LBP) CDMO Service Market Size 2021-2026 ($ millions)
Figure 22. APAC Live Biotherapeutic Products (LBP) CDMO Service Market Size 2021-2026 ($ millions)
Figure 23. Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size 2021-2026 ($ millions)
Figure 25. Americas Live Biotherapeutic Products (LBP) CDMO Service Value Market Share by Country in 2025
Figure 26. United States Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Region in 2025
Figure 31. APAC Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Type (2021-2026)
Figure 32. APAC Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Application (2021-2026)
Figure 33. China Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 37. India Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Country in 2025
Figure 40. Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Type (2021-2026)
Figure 41. Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Application (2021-2026)
Figure 42. Germany Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 43. France Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 56. APAC Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 57. Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 59. United States Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 60. Canada Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 61. Mexico Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 62. Brazil Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 63. China Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 64. Japan Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 65. Korea Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 67. India Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 68. Australia Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 69. Germany Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 70. France Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 71. UK Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 72. Italy Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 73. Russia Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 74. Egypt Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 75. South Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 76. Israel Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 77. Turkey Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
Figure 78. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Live Biotherapeutic Products (LBP) CDMO Service Market Size 2027-2032 ($ millions)
